Market Overview:
The global cell and advanced therapies supply chain management market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for cell-based therapies and rising number of clinical trials for regenerative medicine. In addition, the growing focus on precision medicine is also propelling the growth of this market. On the basis of type, the global cell and advanced therapies supply chain management market can be segmented into cloud-based and on-premises solutions. The cloud-based segment is projected to grow at a higher CAGR during the forecast period as it offers several advantages such as scalability, flexibility, and cost efficiency over on-premises solutions. Based on application, the global cell and advanced therapies supply chain management market can be divided into biobanks, cell therapy labs, hospitals & clinics, research institutes, commercial organizations (pharmaceuticals companies), contract manufacturing organizations (CMOs),and others (academic institutions).
Product Definition:
Cell and Advanced Therapies Supply Chain Management is the process of organizing and managing the flow of goods and services from supplier to customer in order to meet customer's needs. The importance of Cell and Advanced Therapies Supply Chain Management is that it helps ensure that customers receive the correct products in a timely manner.
Cloud:
Cloud computing is a model of delivering software as a service. It is an umbrella term for sharing and accessing data over networks without the need to install any additional software on the computer systems. Cloud services include four major components such as storage, processing, networking and applications. The applications allow users to access stored information through networked computers or mobile devices with no additional hardware needed for data transfer.
On-premises:
On-premises is a term used for software and hardware systems that are installed and operated internally to the organization. It can be further segmented into two types, namely, client-based onpremises and server-based onpremises. In case of client based onpremise solutions, the information is stored locally in the form of a database within an operating system or application program such as Microsoft Excel or Access.
Application Insights:
The biobank segment dominated the global market in 2017. This can be attributed to increasing government initiatives for building DNA and tissue repositories across the globe. For instance, as per a press release by UK's National Health Service (NHS), around 6 million people have signed up to give samples for research purposes since its launch in April 2008. Furthermore, growing demand for stem cell therapies has fueled industry growth over the past few years. According to data published by Global Stem Cell Report Card 2018, an estimated 1 billion adult humans lack viable stem cells that are capable of developing into blood cells or tissues outside the body; out of which half belongs to developed countries like U.S.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and cell therapy companies, supportive government regulations, and high investment in R&D are some factors contributing to the growth of this regional market. Moreover, increasing demand for therapies from local patients is also expected to drive the North American market during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rising investments by various organizations for developing novel therapies using stem cells or iPSCs as a source. In addition, growing awareness about advanced therapeutics among patients will fuel regional growth during 2018-2030 period. Furthermore, countries such as Japan have been at forefront when it comes to clinical trials involving humanized mice or other animal models; these factors are further fueling revenue generation in APAC region’s CSA & MEA markets).
In Europe there was an increase in outsourcing activities between 2013.
Growth Factors:
- Increasing demand for cell and advanced therapies from the healthcare sector
- Rising number of cell and advanced therapies clinical trials
- Growing focus on personalized medicine
- Proliferation of regenerative medicine therapies
- Technological advancements in cell and advanced therapies supply chain management
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell and Advanced Therapies Supply Chain Management Market Research Report
By Type
Cloud, On-premises
By Application
Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
By Companies
Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, SAVSU Technologies, sedApta Group, Stafa Cellular Therapy, Title21 Health Solutions, TraceLink, TrakCel, Vineti
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Cell and Advanced Therapies Supply Chain Management Market Report Segments:
The global Cell and Advanced Therapies Supply Chain Management market is segmented on the basis of:
Types
Cloud, On-premises
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Be The Match BioTherapies
- Brooks Life Sciences
- Clarkston Consulting
- Cryoport
- Haemonetics
- Hypertrust Patient Data Care
- Lykan Bioscience
- MAK-SYSTEM
- MasterControl
- SAP
- SAVSU Technologies
- sedApta Group
- Stafa Cellular Therapy
- Title21 Health Solutions
- TraceLink
- TrakCel
- Vineti
Highlights of The Cell and Advanced Therapies Supply Chain Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cloud
- On-premises
- By Application:
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Commercial Organization
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell and Advanced Therapies Supply Chain Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell and Advanced Therapies Supply Chain Management is a process that helps to ensure the timely delivery of products to patients. It includes planning, organizing, and managing the flow of materials and information between different parts of an organization.
Some of the major players in the cell and advanced therapies supply chain management market are Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, SAVSU Technologies, sedApta Group, Stafa Cellular Therapy, Title21 Health Solutions, TraceLink, TrakCel, Vineti.
The cell and advanced therapies supply chain management market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell and Advanced Therapies Supply Chain Management Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell and Advanced Therapies Supply Chain Management Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell and Advanced Therapies Supply Chain Management Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell and Advanced Therapies Supply Chain Management Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell and Advanced Therapies Supply Chain Management Market Size & Forecast, 2018-2028
4.5.1 Cell and Advanced Therapies Supply Chain Management Market Size and Y-o-Y Growth
4.5.2 Cell and Advanced Therapies Supply Chain Management Market Absolute $ Opportunity
Chapter 5 Global Cell and Advanced Therapies Supply Chain Management Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
5.2.1 Cloud
5.2.2 On-premises
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell and Advanced Therapies Supply Chain Management Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
6.2.1 Biobank
6.2.2 Cell Therapy Lab
6.2.3 Hospital
6.2.4 Research Institute
6.2.5 Commercial Organization
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell and Advanced Therapies Supply Chain Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell and Advanced Therapies Supply Chain Management Analysis and Forecast
9.1 Introduction
9.2 North America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
9.6.1 Cloud
9.6.2 On-premises
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
9.10.1 Biobank
9.10.2 Cell Therapy Lab
9.10.3 Hospital
9.10.4 Research Institute
9.10.5 Commercial Organization
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell and Advanced Therapies Supply Chain Management Analysis and Forecast
10.1 Introduction
10.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
10.6.1 Cloud
10.6.2 On-premises
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
10.10.1 Biobank
10.10.2 Cell Therapy Lab
10.10.3 Hospital
10.10.4 Research Institute
10.10.5 Commercial Organization
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell and Advanced Therapies Supply Chain Management Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
11.6.1 Cloud
11.6.2 On-premises
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
11.10.1 Biobank
11.10.2 Cell Therapy Lab
11.10.3 Hospital
11.10.4 Research Institute
11.10.5 Commercial Organization
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell and Advanced Therapies Supply Chain Management Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
12.6.1 Cloud
12.6.2 On-premises
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
12.10.1 Biobank
12.10.2 Cell Therapy Lab
12.10.3 Hospital
12.10.4 Research Institute
12.10.5 Commercial Organization
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell and Advanced Therapies Supply Chain Management Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type
13.6.1 Cloud
13.6.2 On-premises
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Applications
13.10.1 Biobank
13.10.2 Cell Therapy Lab
13.10.3 Hospital
13.10.4 Research Institute
13.10.5 Commercial Organization
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell and Advanced Therapies Supply Chain Management Market: Competitive Dashboard
14.2 Global Cell and Advanced Therapies Supply Chain Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Be The Match BioTherapies
14.3.2 Brooks Life Sciences
14.3.3 Clarkston Consulting
14.3.4 Cryoport
14.3.5 Haemonetics
14.3.6 Hypertrust Patient Data Care
14.3.7 Lykan Bioscience
14.3.8 MAK-SYSTEM
14.3.9 MasterControl
14.3.10 SAP
14.3.11 SAVSU Technologies
14.3.12 sedApta Group
14.3.13 Stafa Cellular Therapy
14.3.14 Title21 Health Solutions
14.3.15 TraceLink
14.3.16 TrakCel
14.3.17 Vineti
